Unanswered Questions on the Optimal Extent of Tongue Cancer Resections

Area of Science:

• Oncology
• Surgical Pathology
• Head and Neck Surgery

Background:

• Defining definitive surgical margins for mucosal head and neck squamous cell cancers (HNSCC) is complex due to site- and stage-specific molecular alterations.
• The 'barrier clearance' concept, involving tumor entrapment within a compartment, can aid in achieving safe margins but is not universally applicable.
• Recurrent disease poses significant management challenges, potentially requiring extensive surgical interventions.

Purpose of the Study:

• To illustrate the difficulties in achieving adequate surgical margins for mucosal head and neck squamous cell cancers.
• To highlight the challenges in managing recurrent squamous cell cancer (SCC) of the tongue, particularly when the disease spreads to adjacent anatomical regions.
• To underscore the limitations of current surgical margin definitions in complex HNSCC cases.

Main Methods:

• Case report presentation of a patient with recurrent squamous cell cancer (SCC) of the tongue.
• Review of previous surgical interventions, including wide excisions.
• Documentation of disease progression and subsequent treatment, including total laryngectomy.

Main Results:

• The patient experienced recurrence of tongue SCC despite two wide excisions.
• The recurrent disease crossed anatomical barriers, involving the preepiglottic space and extending to the glottis-supraglottic region.
• A total laryngectomy was ultimately required due to the extensive nature of the recurrent disease.

Conclusions:

• Achieving absolute safe surgical margins in mucosal HNSCC is often not feasible due to inherent biological and anatomical factors.
• Tumor spread beyond apparent margins, as exemplified by this case, necessitates careful consideration of compartmental involvement and potential for extensive recurrence.
• Management of recurrent HNSCC requires individualized strategies, acknowledging the limitations of standard surgical margins and the potential for aggressive disease progression.